NCT05678010 A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05677308 LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS) Status COMPLETED Phase N/A
NCT05677139 A Study for Observing Severe Asthma in Patients Treated With Tezepelumab Status COMPLETED Phase N/A
NCT05668936 A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants Status TERMINATED Phase PHASE1
NCT05667493 An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05667298 Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05667064 Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study Status COMPLETED Phase N/A
NCT05665374 Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study Status COMPLETED Phase N/A
NCT05663957 eVusheld Assessment reaL wORld Effectiveness in the VA Health System Status COMPLETED Phase N/A
NCT05663515 A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs Status RECRUITING Phase N/A
NCT05662033 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State. Status COMPLETED Phase PHASE1
NCT05659914 Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05648110 Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study Status COMPLETED Phase PHASE2/PHASE3
NCT05645172 Retention Rate of Acalabrutinib in a Non-interventional Setting Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05644600 A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants. Status TERMINATED Phase PHASE1
NCT05638737 A Study in Participants With Non-cirrhotic NASH With Fibrosis Status COMPLETED Phase PHASE2
NCT05637112 A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice Status ACTIVE_NOT_RECRUITING Phase N/A